Imperial Innovations Group Share News (IVO)
IVO Share
IVO Share
IVO Share
IVO Share
IVO
IVO Share
IVO Broker
IVO Directors
IVO Financial
IVO
IVO Short
IVOWed, 16th Oct 2013 11:25
Balfour Beatty: Berenberg lowers target price from 290p to 280p and retains a buy recommendation. UBS lowers target price from 230p to 225p and keeps a neutral rating. Barclays: Citi lowers target price from 305p to 300p and keeps its sell recommendation. Clinigen: Investec cuts target price from
Read more
By Nishant Kumar LONDON, July 7 (Reuters) - Star British fund manager Neil Woodford, who left Invesco Perpetual in April to start his own firm, is beginning his new role with a focus on tobacco and drug stocks, believing they can withstand what he expects will be a faltering global economy.
Read moreA total of £150m is the sum being targeted by AIM-listed Imperial Innovations, which on Monday launched the placing of 37.5m shares at 400p each. At the same time, the UK's Imperial College is trading in 2.56m shares at the same price, reducing its stake from 30.2% to 20%, taking the overall placin
Read more* CEO says Convergence could raise 50-100 million pounds * Follows success for pain drug in mid-stage trial * UK biotech sector boosted by Circassia IPO in March * Biotech support firm Abzena also announces plan to float By Ben Hirschler LONDON, June 16 (Reuters) - C
Read more
LONDON (Alliance News) - UK shares are narrowly mixed at the open Monday, as events in Iraq and Ukraine damp investor sentiment. Low-cost airline Wizz Air Holdings PLC has pulled its planned initial public offering in London, blaming the recent volatility in airline stoc
Read moreLONDON (Alliance News) - Imperial Innovations Group PLC Thursday said it has invested a further GBP1.5 million in visual search company Cortexica Visual Systems Ltd. The technology commercialisation and investment group first invested in Cortexica in 2009. It said it will now hold, on conve
Read moreImperial Innovations, the AIM-listed firm which focuses on commercialising UK academic research, has completed a £3m investment round in behavioural analytics business, Featurespace. The group has invested £1.7m into the round with the balance coming from Nesta and members of the Cambridge Angels g
Read moreLONDON (Alliance News) - Imperial Innovations Group PLC Tuesday said it has invested GBP1.7 million in the behavioural analytics business, Featurespace, as part of a larger investment round. As a result, the mobile payments company said it now holds a 22.1% equity stake in Featurespace.
Read moreImperial Innovations, the AIM-listed firm which focuses on commercialising UK academic research, pleased the market on Wednesday with the news that its portfolio company Autifony Therapeutics has been awarded a grant from the Technology Strategy Board (TSB). TSB has given £2.2m of funding to Autifo
Read moreLONDON (Alliance News) - Imperial Innovations Group PLC said Wednesday its portfolio company, Autifony Therapeutics Limited, has won GBP2.2 million in funding from the Technology Strategy Board for its Phase II clinical trial into tinnitus. Autifony is working on the development of novel ph
Read moreImperial Innovations' decision to raise up to £150m may be a golden opportunity for investors. The shares are tightly held but existing investors in the group have decided that the placing will be non-pre-emptive. That means new shareholders will be allowed in, including retail ones should there be
Read moreImperial Innovations Group has proposed raising up to £150m through the placement of shares to fund its existing portfolio and source investment opportunities in new technologies. The UK technology transfer and commercialisation company will place ordinary shares at no less than 400p each. Chair
Read more
